Eszopiclone 2 mg
Sponsors
Eisai Co., Ltd., University of California, San Diego
Conditions
Obstructive Sleep ApneaPrimary Insomnia
Phase 2
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
CompletedNCT00770510
Start: 2008-09-30End: 2010-05-31Updated: 2013-02-04
Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)
CompletedNCT05951023
Start: 2023-08-31End: 2025-10-01Updated: 2025-11-25